Brain Tumor Treatments: Minnesota

Sponsored By

Please Click On The Above Banner For More Details

Search Term: Minnesota
Please scroll down to see the matching trials.

  (0.8510) Brain Tumor Survivor Stories
  (0.8351) Advanced Search
  (0.8169) Brain Tumor Treatments: Minnesota
  (0.7742) Brain Tumor Activism
  (0.7742) Letter Writing Wizard
  (0.7742) Brain Tumor Activism
  (0.7742) Virtualtrials Newsletter
  (0.7742) Untitled Document
  (0.7742) Brain Tumor Survivor Stories
  (0.7742) Brain Tumor Survivor Stories

Sorry - There were no pages found that contain that search phrase.


	Previous 25 Showing Treatment 26 to 37 of 37	Location	Last Updated

Details	Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma	Duluth, MN USA	11/27/2005

Details	Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma	Saint Louis Park, MN USA	11/27/2005

Details	Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors	Minneapolis, MN USA	11/26/2005

Details	Thalomid™ and Carboplatin for the Treatment of Pediatric Brain Stem Glioma	Minneapolis, MN USA	11/26/2005

Details	Thalomid™ and Carboplatin for the Treatment of Pediatric Brain Stem Glioma	St. Paul, MN USA	11/26/2005

Details	Phase II Study of Multi-Agent Intrathecal and Systemic Chemotherapy With Radiotherapy in Children With Newly Diagnosed Central Nervous System Atypical Teratoid/Rhabdoid Tumors	Minneapolis, MN USA	11/21/2005

Details	A Multicenter Phase II Study of TP-38 in Those Patients With Glioblastoma Multiforme Who Have Recurred or Progressed After Previous Resection and Radiation Therapy and Are Scheduled for Gross Total Resection	Minneapolis, MN USA	11/13/2005

Details	FR901228 in Treating Children with Refractory or Recurrent Solid Tumors or Leukemia	Rochester, MN USA	11/11/2005

Details	FR901228 in Treating Children with Refractory or Recurrent Solid Tumors or Leukemia	Minneapolis, MN USA	11/11/2005

Details	Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors	Rochester, MN USA	11/11/2005

Details	Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors	Minneapolis, MN USA	11/11/2005

Details	Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors	Rochester, MN USA	11/06/2005

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By